Questions should be raised about what role the Proud Boy’s leader may have played in the Capitol uprising, given his past as an FBI confidential source, writes Coleen Rowley.
Daniel Farber says the most consequential phase of the high-stakes litigation may be during discovery; when the companies make disclosures that could reach the public.
In marking the anniversary of the Egyptian uprising, it is deceptive to celebrate a revolution. The word “revolution” has been bandied about a lot since 2011, writes As’ad AbuKhalil.
“Instead of spending on innovation, Big Pharma is hoarding its money for salaries and dividends,” the report says, “all while swallowing smaller companies, thus making the marketplace far less competitive.”
Ann Wright reports that Blinken, rather than acknowledging the danger of these exercises, has criticized their suspension as an appeasement of Pyongyang.